After 31 Years Developing Skin Medications, a Pharmacologist Exposed the Real Reason 31 Million Americans With Eczema Never Get Better — And Was Banned From Publishing

Former senior formulation scientist at [Redacted Pharmaceutical] reveals “The Escalation Ladder” — a $14 billion, 5-rung strategy designed to keep you itching for life — and the internal discovery that ended 25 years of clawing herself bloody every night (no steroids, no $40,800/year biologics, no immune suppressants)

I need to tell you something that will probably end what’s left of my career in pharmaceutical science.

I’ve spent 31 years formulating topical medications. I’ve held patents. I’ve sat in rooms where we decided which compounds would go to Phase III trials and which would be shelved — not because they didn’t work, but because they worked too well and couldn’t be sold repeatedly.

But that’s not why I’m writing this.

I’m writing this because of what happens to me every night at 11:40 PM.

That’s when it starts. Not at midnight, not at some dramatic hour. 11:40. My body temperature shifts as I settle into bed, and the first itch blooms at the inside of my left elbow. I know I shouldn’t scratch. I’ve known this for 25 years. I have a doctorate in pharmacology. I’ve literally formulated the creams that are supposed to stop this.

I scratch anyway.

By midnight, both arms are on fire. I move to my shins. The backs of my knees. The skin on my neck where my pillowcase touches. I scratch through my sleep shirt. I scratch in half-sleep, that horrible twilight where you’re conscious enough to feel the pain but not conscious enough to stop your hands.

At 2 AM, I wake up fully. The sheets are spotted. Not a lot — just enough. A smear on the fitted sheet where my elbow was. A small rusty stain near my ankle. Under my fingernails, there are thin rolls of my own skin.

I get up. I wash my hands — and the water hits the raw patches on my knuckles, and for three seconds, the pain is so sharp and clean that it actually replaces the itch. I stand at the bathroom sink and breathe.

This has been my life since I was 27 years old.

I am not telling you this for sympathy. I’m telling you because if you found this page, there is a very good chance you just nodded. You know the 11:40 PM itch. You know the sheets. You know the fingernails. And you know the specific shame of being a grown adult who cannot stop tearing at their own body in the dark.

The Morning Negotiation

The morning routine of a person with chronic eczema is something no dermatologist has ever accurately described in a medical textbook. I know — I’ve read them all.

Here is what they don’t write:

You shower fast. Not because you’re in a hurry, but because every second of water on broken skin is a second of stinging. You don’t use the body wash your family uses. You have your own — unscented, $14 a bottle, and it still burns on bad days. You don’t towel off normally. You pat. Gently. Like you’re handling something fragile. Because you are.

Then you have exactly three minutes.

Three minutes before the moisture on your skin evaporates and the tightness begins. In those three minutes, you apply your emollient — not lotion, emollient, the thick, greasy kind that leaves fingerprints on everything you touch for the next hour. You do your arms. Your legs. The backs of your hands. Your neck. If it’s a bad day, your eyelids.

Then you stand in your closet and negotiate with your wardrobe.

Not “what looks good today.” That’s a luxury you gave up years ago. The negotiation is: What won’t make it worse? Cotton, always cotton. No tags — you cut them all out years ago, and the little stumps still scratch. No wool, ever. No polyester against the skin. In winter, you layer cotton under everything and sweat. In summer, you wear long sleeves and people ask if you’re cold.

You are not cold. You are hiding.

Then you go to work. I worked in a pharmaceutical laboratory — eight hours a day, latex gloves over cracked, split skin. Every time I washed my hands with ethanol-based sanitizer between procedures, the sting was so intense I had to grip the edge of the sink and wait for it to pass. Some days I stepped outside just to breathe. My colleagues thought I needed rest. I didn’t need rest. I needed skin that didn’t crack open every time I flexed my fingers.

And the exhaustion. Twenty-five years of broken sleep does something to your mind that no amount of coffee fixes. I made mistakes in the lab — small ones, caught before they mattered, but I noticed them. A pharmacologist with 23 years of experience miscalculating a dilution because she hadn’t slept more than four consecutive hours in a week. I was ashamed of errors I could explain to no one.

There were nights when the itch was so relentless, so deep, that I stared at my fingernails and thought: if I scratch deep enough, hard enough, maybe I’ll reach the layer that doesn’t itch anymore. That is not self-harm. That is pure, distilled desperation. When your body refuses to give you rest, you will consider anything — anything — to make it stop. Even destroying the very skin you’re trying to save.

I hid for 25 years. Through my PhD. Through my career at one of the largest pharmaceutical companies in the world. Through two marriages — the second one ended not because of a single event but because of a thousand small ones. I flinched when he touched my arms. I wore long sleeves to bed. He could hear me scratching in the bathroom at 2 AM. He wanted to help. I didn’t want anyone to see.

“It’s just dry skin,” he said once. Just dry skin.

If you have eczema, that sentence just made your jaw tighten. Because you’ve heard it. From partners, from coworkers, from well-meaning relatives who send you links to coconut oil articles. And every time you hear it, you feel a little more alone. Because they don’t understand that “dry skin” doesn’t wake you up bleeding. “Dry skin” doesn’t make you cancel plans because your neck is so raw that a collared shirt feels like sandpaper. “Dry skin” doesn’t make you cry in a pharmacy parking lot because the third prescription this year isn’t working either.

I estimate I’ve spent $47,000 on eczema over 25 years. Dermatologist visits, four times a year at $250 each. Steroid prescriptions. Immunosuppressants. Biologics. Specialty emollients. Cotton clothing. Bedsheets replaced every three months because blood doesn’t wash out fully — it leaves a shadow, a faint yellow ghost that reminds you every time you change the sheets. $47,000, and I was still scratching every night.

I cried in a pharmacy parking lot in 2019. I was 47 years old. I had a doctorate. I had 23 years of experience formulating the exact category of medication I’d just picked up. And I sat in my car and cried, because I knew — with the full weight of my professional expertise — that what was in that bag would not fix me. It would suppress my symptoms for four to six weeks, then my skin would rebound worse than before, and I would be back.

I had always known this. But that day, sitting in that parking lot in Durham, North Carolina, something shifted. Not anger — I was past anger. It was a quieter feeling. The feeling of a scientist who finally admits that the question she’s been avoiding is the only question that matters:

Why does nothing I make actually work?

To answer that question, I need to walk you through everything I tried first — and why every single one of them failed.

The Escalation Ladder

I want to walk you through what the pharmaceutical industry calls a “treatment pathway” for chronic eczema. In practice, it’s a ladder. And you only go up.

Rung 1 — Over-the-counter emollients. This is where everyone starts. CeraVe. Eucerin. Aveeno. You buy them at CVS, you apply them religiously, and for mild eczema, they help. For chronic eczema — the kind that wakes you up at night — they are a bandage on a broken pipe. I used them for three years before my PCP referred me to a dermatologist. Cost: roughly $40/month. $1,440 over three years. Effectiveness on my eczema: zero.

Rung 2 — Topical corticosteroids. My dermatologist prescribed hydrocortisone, then triamcinolone, then clobetasol — each one stronger than the last. I am a pharmacologist. I knew the mechanism. I knew the risks. I used them anyway because at 2 AM, when your forearms feel like they’re wrapped in fiberglass, you will use anything.

Seven years of topical steroids. Here’s what they did to my hands: the skin became translucent. I could see the veins on the backs of my hands as clearly as if they were drawn in blue ink. The technical term is “steroid atrophy.” I was thinning my own skin with the medication I was supposed to be protecting it with. Cost: $80–200 per tube, refilled monthly for seven years.

My dermatologist said, “We need to step up.”

I knew what that meant.

Rung 3 — Immunosuppressants. Cyclosporine. A drug originally developed for organ transplant recipients. I took it for 14 months. My eczema improved 60%. My blood pressure went up. My kidney function markers shifted. My dermatologist monitored me with blood draws every six weeks — $150 per draw.

When I stopped — because you can’t take cyclosporine indefinitely — my eczema returned within 19 days. Not to baseline. Worse than baseline. This is called “rebound flare,” and every chronic eczema patient reading this just felt their stomach drop, because you’ve lived it.

Rung 4 — Biologics. Dupixent. $3,400 per month before insurance. $40,800 per year. Self-injected every two weeks. I’m a scientist — I inject things for a living — and I still had to sit on my bathroom floor for ten minutes before the first injection, not because of the needle, but because of what it meant. It meant everything else had failed.

Dupixent worked. For eleven months, I had the best skin of my adult life. Then I developed conjunctivitis — a known side effect. Then facial eczema I’d never had before — also a known side effect. My ophthalmologist and dermatologist had a polite disagreement over my body, and I sat between them thinking: I formulate drugs. I know what’s happening. The biologic is redirecting my immune response, not resolving it. It’s a detour, not a fix.

I stopped Dupixent. My eczema returned in 23 days.

Rung 5 — “Manage your condition.” This is the top of the ladder. There is no Rung 6. Your dermatologist says it gently, with genuine compassion, because they are not bad people. They say: “Margaret, we’ve tried everything in our toolkit. At this point, we focus on management.” And you nod. And you go home. And you buy new sheets — dark ones, so the blood doesn’t show as much.

I bought charcoal gray sheets in 2021. I remember standing in the aisle at Target, holding two sets — one gray, one white — and choosing gray because it would hide the stains better.

That is what “management” looks like.

The Yellow Legal Pad

After 25 years on every rung of that ladder, and 31 years inside the industry that built it, I sat down one evening at my home office in Durham — a room full of pharmacology textbooks and framed patents with my name on them — and I wrote a single question on a yellow legal pad:

Every treatment I’ve ever made, taken, or studied targets the skin. What if the skin isn’t where this starts?

It was, honestly, a question I should have asked 20 years earlier. But when you work inside a system, you stop questioning the system’s assumptions. The assumption in dermatology is that eczema is a skin disease. It presents on the skin. It’s treated on the skin. It’s managed on the skin. Every drug I’d ever formulated — every cream, every ointment, every topical solution — was designed to be applied to the skin.

But the skin is where eczema ends. Not where it begins.

What I found over the next 14 months changed everything I understood about this condition. And I need to explain it to you, because once you see it, you cannot unsee it — and you will understand, with perfect clarity, why nothing your dermatologist has given you has ever produced lasting results.

The 14-Month Obsession

I want to be honest about what this looked like, because it wasn’t glamorous.

For 14 months, after my regular work hours, I sat at my kitchen table with a laptop and read. Every night. Sometimes until 1 AM, which was ironic — I was losing sleep to research a condition caused partly by losing sleep.

I reviewed 847 published papers across three fields that rarely talk to each other: immunology, gastroenterology, and microbiology. Dermatologists read dermatology journals. Gastroenterologists read gastroenterology journals. Almost nobody was reading across all three. But eczema doesn’t respect academic departments. It lives in the space between them.

I spent $18,000 of my personal savings on medical database subscriptions, full-text article access, and three trips to university libraries with archives I couldn’t access remotely. $18,000 — almost as much as a year of dermatologist visits and steroid prescriptions.

I emailed 41 researchers whose work touched gut microbiome composition and atopic dermatitis. Six replied. Two agreed to extended discussions. One of them — Dr. Yamamoto at Keio University in Tokyo — shared unpublished data on the relationship between interleukin-31 production and intestinal permeability that hadn’t yet made it into any journal. That data changed the direction of everything.

For the first three months, I was certain I was wrong. Correlation is not causation. I was seeing patterns because I wanted to see them. By month four, I began to notice convergence — independent research groups in different countries, using different methodologies, arriving at the same conclusion. By month nine, I stopped doubting and started designing.

Two compounds kept appearing across the literature. The same two, study after study, country after country. Not hundreds of candidates narrowed to two — two that were simply, repeatedly, there.

Learn more

I Tested It On Myself

I want to be precise about what happened, because exaggeration is what supplement companies do, and I refuse to do it.

Weeks 1–2: Nothing visible. My eczema did not improve. I had mild digestive changes — slight nausea the first three days (oregano oil on an empty stomach — I should have known), which resolved once I started taking the softgels with meals. I noted this in my journal and continued.

Week 3: The first thing that changed was not my skin. It was my sleep. I woke up on a Tuesday morning and realized I had not scratched during the night. Not reduced scratching — none. My sheets were clean. I stared at them for a long time. I did not want to hope. Hope, when you've had eczema for 25 years, is a dangerous thing.

Weeks 4–6: The itch frequency decreased measurably. I was tracking it — because that's what I do — using a simple 1–10 scale every morning and evening. My average evening score dropped from 7.2 to 3.8 over this period. The patches on my inner elbows, which had been dark and thickened for years (lichenification — your dermatologist may have used this word), began to soften. The redness reduced. The texture was changing.

Week 5: I washed my hands in the lab with ethanol sanitizer and didn't wince. I stood at the sink for a moment afterward, not because it hurt, but because it didn't. I couldn't remember the last time it didn't.

Week 7: I stopped carrying bandaids in my lab coat pocket. I'd carried them every day for twelve years. I noticed the pocket was empty and couldn't remember when I'd stopped refilling it.

Weeks 8–12: I wore a short-sleeved shirt to the grocery store. I'm stating this plainly because I need you to understand what that sentence means. I had not worn short sleeves in public in over nine years. It was July in North Carolina. I wore a short-sleeved shirt. Nobody looked at my arms, because there was nothing to look at.

I stood in the produce aisle and cried for the second time in a grocery store.

But this time, it was a different kind of crying.

Erin, Then Others

I shared my data — not my hope, my data — with one colleague. Dr. Erin Park, a microbiologist in my department. Erin had eczema on her hands for 12 years. Lab work was agony for her: gloves over cracked skin, eight hours a day, washing with ethanol-based sanitizer between procedures. Her knuckles bled so often she kept bandaids in every pocket of her lab coat.

Erin was skeptical. She should have been — she's a good scientist. She asked me for the literature. I gave her 19 papers. She read them over a weekend and started the protocol on Monday.

Erin's results tracked mine closely. By week 5, the cracking on her hands had stopped. By week 9, she removed her gloves during a meeting for the first time in years without thinking about it — then froze, looked at her hands, and looked at me.

She didn't say anything. She didn't need to.

Over the following months, Erin and I shared the protocol with a small group — colleagues and their family members. I was not running a clinical trial. I want to be very clear about that. I was a private citizen sharing a combination of two over-the-counter dietary supplements with people who asked. What I was doing was asking each person to track their response systematically, because the scientist in me couldn't help it.

Within six months, we had 47 tracked cases with detailed data. And I started receiving emails I still can't read without my throat tightening.

One was from a man in Dallas. Subject line: "I took off my gloves today." Robert was a construction foreman, 58, eczema on both hands for 15 years. He wore work gloves every day — not for safety, but to hide his skin. His crew assumed it was a safety thing. He never corrected them. After eight weeks, he took off the gloves during lunch break. His crew didn't say anything. He wrote to me: "Nobody said a word. That was the best compliment I've ever gotten."

One was from a teacher in Minneapolis. Subject line: "Ms. Martinez looks different today." Angela, 44, eczema on her neck. She wore scarves every single day, even in heated classrooms. Her students asked if she was cold. Every day. After six weeks, she came to school without the scarf. A student said, "Ms. Martinez, you look different today." Angela just smiled. She wrote to me: "I didn't explain. I just smiled. I haven't smiled like that in so long."

One was from a retired woman in Scottsdale. Subject line: "I felt worthy." Diane, 67, eczema across her arms and chest for 30 years. Her husband had passed away two years earlier. She wanted to start dating again but couldn't imagine anyone seeing her skin. After twelve weeks, she went on a first date. She wore a sleeveless dress. She wrote to me: "I felt worthy of being looked at again."

Across the 47 tracked cases, the patterns were consistent: sleep improved before skin in over 80% of cases. Average itch scores dropped roughly 60% by week 6. Lichenification began softening by week 8. These are not clinical trial numbers — they are observations. But they are real.

Learn more

I Tried To Publish

I want you to know that I tried to do this the right way.

I didn't start with a website. I started with a manuscript. I submitted our observational data — my own case, Erin's, and 31 others who had tracked their outcomes systematically — to three peer-reviewed journals over nine months.

The first two rejections were standard. Small sample size, no control group, observational only. Fair criticisms. I accepted them.

The third rejection was different.

The editor — someone I'd met at conferences, someone whose work I respected — sent a personal email along with the formal rejection. I will not quote it in full, but one sentence has stayed with me:

I sat with that email for a long time.

Then I submitted an abstract to present at a dermatology conference. It was accepted. I prepared my slides. Forty-eight hours before my session, the organizer called me. One of the conference's primary sponsors — a manufacturer of a biologic eczema drug that costs $40,800 per year — had "expressed concerns" about my presentation. My session was removed from the schedule.

Then the phone calls started.

Dr. David Kaufman — my former mentor, a man I'd known for twenty years, a man who'd written the recommendation letter for my first industry position — called me on a Thursday evening. His voice was careful. "Margaret, don't do this. You'll never be invited to lecture again. You'll lose every consulting contract you have. Think about your retirement. Think about your reputation."

I said: "David, I haven't slept through the night in 25 years. Consulting contracts are not what keeps me awake at 2 AM."

He was quiet for a long time. Then he said, "I understand. But they won't."

He was right. They didn't.

Three weeks after the conference removal, the Turkish supplier I'd been sourcing high-concentration carvacrol from informed me they were "temporarily out of stock." The timing was suspicious. I later learned that a major pharmaceutical company had sent an inquiry to the same supplier, asking about customers placing small-quantity orders of concentrated oregano oil extract. My supplier got nervous. Supply disappeared overnight.

I flew to Ankara. I sat in a warehouse smelling oregano oil samples from three different producers. I'm a pharmacologist with a doctorate and 31 years of experience. I was in a Turkish warehouse with a translator, testing carvacrol concentration with a portable assay kit. This is what happens when you ask the wrong question in the right industry.

I found a new supplier. Higher quality, actually. The disruption cost me six weeks and $4,200 in travel.

Then came the letter. Not a cease-and-desist — something subtler, and in some ways worse. A "letter of professional concern" from the regional dermatology association, cosigned by three board members I'd once considered colleagues. It requested that I "discontinue making therapeutic claims outside of peer-reviewed channels" and "reconsider the reputational implications of associating your credentials with unverified commercial products."

I read it twice. I put it in a drawer. And then I opened my email.

Three new messages from strangers. One from Portland: "Dr. Ashford, last night my daughter hugged my bare arms for the first time. She's eight. She's never touched my arms without a layer of fabric between us. She didn't know that. I did."

I read that email three times and cried at my kitchen table.

I'm not going to be dramatic about what happened. There is no shadowy conspiracy to keep you sick. The reality is more mundane and, honestly, more depressing than that. There is an industry — a $14 billion global eczema treatment industry — that is structured around managing a condition, not resolving it. The people in that industry are not evil. Many of them are my friends. Many of them are good scientists trapped in a system with misaligned incentives. But the system they work within has no financial motivation to investigate approaches that cost $0.58 per day and don't require a prescription.

That's not a conspiracy. It's just economics. And it's why I'm writing on this page instead of in a journal.

From Kitchen Table to Softgels

I need to explain how this went from a personal protocol to a product, because the path matters.

After the third journal rejection, I made a decision I never expected to make. I would make this formulation available directly. Not because I wanted to sell supplements — I spent 31 years in pharmaceutical science; I understand how this looks. But because I realized that waiting for academic acceptance could take five more years. Five more years is five more years of millions of people clawing themselves bloody every night while a $14 billion industry repainted their walls.

The first version wasn't a product. It was an email.

Erin had posted our early results on an internal research forum — not public, just an academic discussion board. A member shared the thread on Reddit, on r/eczema. Neither Erin nor I had posted it. A patient found it, shared it, and within a week, I started receiving emails from strangers asking for the formula.

So I sent it. For free. Just the compounds, the concentrations, and instructions: "Buy oregano oil with at least 70% carvacrol and cold-pressed black seed oil. Take X amount daily with food."

It didn't work. Not the formula — the delivery. People bought the wrong oregano oil (culinary grade, 3% carvacrol). They bought black seed oil capsules filled with soybean oil. They tried liquid oregano oil, gagged, and quit after two days. One woman wrote: "I'd rather have the eczema than taste that again."

I realized that a formula without standardization was useless. If I wanted the protocol to actually reach people — at the right concentration, in a form they'd actually take consistently — I needed to manufacture it.

I contacted seven GMP-certified supplement manufacturers. Five declined. "Minimum order 50,000 units." "We don't do custom formulations under 10,000 units." Two were willing to work with a small first batch. I chose a facility in Utah — FDA-registered, GMP-certified, willing to produce 500 pouches as a first run.

Why softgels: I'd taken liquid oregano oil for three months during my self-test. Every single time was like swallowing paint thinner mixed with cooking oil. Compliance isn't a footnote in pharmacology — it's the entire game. If people can't tolerate taking it, the best formula in the world is worthless. Softgels solved this.

I designed the label myself using Canva. I built the website watching Shopify tutorials at 2 AM. The first orders came in through a Google Form and a PayPal link. I packed the first 200 pouches in my garage and drove them to the post office in three trips.

I named it Oreganix because I'm a scientist, not a marketer, and it was the most straightforward name I could think of.

Each batch is third-party tested by an independent laboratory: carvacrol content verified at ≥70%, heavy metals screening, microbial contamination testing, thymoquinone concentration confirmation. Certificates of Analysis are available upon request. I didn't spend 31 years in pharmaceutical science to cut corners on the one product with my own name on it.

What's In The Pouch

The formula is simple — deliberately so. Two active ingredients, the same ones I've been taking for over two years:

Two softgels per serving. 120 softgels per pouch. 60 servings. No proprietary blends hiding behind vague labels — you know exactly what you're taking and exactly how much. No filler ingredients. No artificial colors. No ingredients I wouldn't take myself.

I didn't create this for marketing. I created it because I was clawing my own skin off at 2 AM and I had a doctorate in the exact science that should have prevented it.

What Else the Pipeline Fixes

I formulated Oreganix for eczema. That's what I know. That's what I've lived with for 25 years, and that's what the 47 tracked cases are about.

But something unexpected happened in the first six months.

People started reporting improvements I hadn't predicted. Not skin improvements — other things. Things that, in retrospect, make perfect sense when you understand the pipeline, but that I didn't anticipate because I was focused on eczema and nothing else.

Robert — the construction foreman from Dallas — emailed me six weeks after his eczema update. Subject line: "Something else happened." He'd had chronic sinusitis for ten years. Constant congestion, post-nasal drip, sinus headaches three times a month. After two months on the protocol, his sinuses cleared. He hadn't mentioned sinusitis to me because he wasn't taking the softgels for sinusitis. He was taking them for his hands.

Angela — the teacher — reported that recurring Candida infections she'd dealt with three to four times per year had stopped entirely.

A woman I'd never met, who'd found the Reddit thread and ordered directly from my website, wrote to say her IBS symptoms had reduced by what she estimated as 70%. "I can eat a meal without planning my route to the nearest bathroom," she wrote.

This makes sense. Carvacrol is a documented broad-spectrum antimicrobial — it doesn't just target eczema-related biofilm. It disrupts opportunistic organisms throughout the gut, including Candida overgrowth and bacterial imbalances linked to sinusitis, SIBO, and digestive dysfunction. Thymoquinone's anti-inflammatory and immunomodulatory properties don't stop at the gut-skin axis — they support immune regulation system-wide.

I'm not claiming Oreganix cures sinusitis or IBS or Candida. I'm telling you what people reported, and I'm telling you that the published research on these compounds is consistent with those reports.

A quality multivitamin costs $1.00 per day and doesn't do any of this.

Who Should Not Take Oreganix

I'm a pharmacologist. "Natural" does not mean "safe for everyone." Oregano oil is a potent compound — that's why it works, and that's why you need to use it correctly.

Take 2 softgels daily with a meal. Do not exceed this dose. More is not better — this is a concentrated extract. Do not take on an empty stomach unless you enjoy nausea.

I'm telling you this because every supplement company that says "safe for everyone, no side effects" is either lying or doesn't understand their own product. Oregano oil is effective precisely because it is bioactive. Bioactive means it does things in your body. That's the point. But it also means it's not for everyone, and you should be informed.

What to Expect (Honestly)

I will not promise you miracles. I will tell you what I observed in myself and in the people who've shared their data with me.

Learn more

The numbers below come from two places: the 47 cases we tracked systematically before Oreganix® existed, and the customers who have ordered since.

Check out what real users with verified purchases are saying:

The Math They Don't Want You to Do

Let me show you what eczema actually costs — the number you've been trying not to add up.

The Conservative Route (dermatologist + topicals):
4 dermatologist visits/year × $250 = $1,000. Steroid cream prescriptions: $600/year. Specialty emollients: $480/year. Cotton clothing replacements: $300/year. Bedsheets (blood stains): $200/year. "Natural remedies" you found online: $500/year.
Total: $3,080 per year. Every year. With the same itch every night.

The Biologic Route (Dupixent):
$3,400/month × 12 = $40,800/year. Plus dermatologist monitoring. Plus ophthalmologist for conjunctivitis side effects. Plus facial eczema treatment for the new eczema Dupixent created.
Total: $43,800+ per year. For a detour, not a fix. Stop taking it, and 23 days later you're back where you started.

The "Kitchen Sink" Route (everything):
Dermatologist + immunologist + TCM practitioner ($6,800 for Margaret) + supplements + laser + Dupixent trial + cyclosporine monitoring.
Total: $12,000–50,000 over a few years. I know. I spent $47,000.

Oreganix:
$0.58 per day for the starter supply. $0.39 per day if you choose the 3-pack (which 84% of returning customers do). That's $142–$213 per year.

$213 per year. Less than a single dermatologist visit. Less than one month of specialty emollients. Less than three days of Dupixent.

I spent $47,000 over 25 years. If someone had handed me two softgels at age 27, I would have saved $47,000 and 9,125 sleepless nights.

I cannot get those nights back. But I can make sure you don't lose the next one.

A Note About Other Websites

You may have seen other pages selling oregano and black seed oil for skin conditions. Some of them use dramatic language, fake clinical trials, and manufactured urgency. "847 patients." "Confirmed by Johns Hopkins." "Only 37 pouches left."

I've seen them too, and they make me angry — because they exploit the same science I spent 14 months and $18,000 verifying, package it in manipulative marketing, and undermine the credibility of the actual research.

That's it. No fake urgency. No invented credentials. Just a pharmacologist who couldn't sleep for 25 years and finally figured out why.

Learn more

Two Paths

You have a decision to make. Not a purchase decision — a direction decision.

HERE'S EXACTLY WHAT HAPPENS NEXT

Start tonight.

Learn more Learn more

HEALTH WATCH: An internal supplement protocol is generating attention among chronic eczema sufferers

A formulation developed by Dr. Margaret Ashford, a pharmacologist with 31 years of industry experience, is gaining traction among adults with chronic eczema who have exhausted conventional treatment options. The protocol targets the gut-skin axis — a biological pathway linking intestinal health to skin inflammation — using two concentrated natural compounds: carvacrol (from oregano oil) and thymoquinone (from black seed oil). Early tracked cases suggest meaningful improvements in itch reduction and sleep quality within 3–6 weeks, without steroids or immunosuppressants. The formulation is available directly at the Oreganix website.

Here are the results people over 50 have experienced:

Learn more